People Background Check
Find People:

Scott S Harried, Age 563061 W Main St, Sun Prairie, WI 53590

Get Report
Known as:
Scott H Harried Scott S Harned Scott S Harrier Harried Harried Scott Harred

Scott Harried Phones & Addresses

3061 W Main St, Sun Prairie, WI 53590 (608) 825-1941

803 Fairgate Dr, Wexford, PA 15090

Madison, WI

Pittsburgh, PA

22248 Archwood St, Canoga Park, CA 91303 (818) 347-1065

Woodland Hills, CA

San Francisco, CA

Los Angeles, CA

Gibsonia, PA

803 Fairgate Dr, Wexford, PA 15090 (818) 621-1829

Show more

Social networks

Scott S Harried

Linkedin

Work

Company: Sta pharmaceutical, a wuxi apptec company Sep 2020 Position: Senior process research and development scientist

Education

School / High School: Harvard University 1999 to 2000 Specialities: Organic Chemistry

Skills

Medicinal Chemistry • Organic Synthesis • Organic Chemistry • Chemistry • Heterocyclic Chemistry • Drug Discovery • Analytical Chemistry • Drug Design • Oncology • Adme • Biotechnology • Clinical Development • Multi Step Organic Synthesis • Small Molecules • Lc Ms • Teacher Training • Pharmaceutical Industry • Hplc • Neuroscience • Lead Change • Drug Development • Problem Solving • Teaching Experience

Industries

Pharmaceuticals

Mentions for Scott S Harried

Scott Harried resumes & CV records

Resumes

Scott Harried Photo 15

Senior Process Research And Development Scientist

Location:
3061 west Main St, Sun Prairie, WI 53590
Industry:
Pharmaceuticals
Work:
Sta Pharmaceutical, A Wuxi Apptec Company
Senior Process Research and Development Scientist Centrose Pharma Oct 2014 - Mar 2017
Director of Chemistry Nanoclear Technologies Oct 2014 - Mar 2017
Director of Chemistry Knopp Biosciences May 2012 - Oct 2014
Senior Research Investigator Amgen 2002 - 2011
Senior Scientist Genentech Aug 2000 - Feb 2002
Scientist
Education:
Harvard University 1999 - 2000
University of California, Los Angeles 1992 - 1998
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry University of Wisconsin - Platteville 1987 - 1992
Bachelors, Chemistry
Skills:
Medicinal Chemistry, Organic Synthesis, Organic Chemistry, Chemistry, Heterocyclic Chemistry, Drug Discovery, Analytical Chemistry, Drug Design, Oncology, Adme, Biotechnology, Clinical Development, Multi Step Organic Synthesis, Small Molecules, Lc Ms, Teacher Training, Pharmaceutical Industry, Hplc, Neuroscience, Lead Change, Drug Development, Problem Solving, Teaching Experience

Publications & IP owners

Us Patents

Piperazine Derivatives And Methods Of Use

US Patent:
7393852, Jul 1, 2008
Filed:
Jun 21, 2004
Appl. No.:
10/874086
Inventors:
Jian J. Chen - Newbury Park CA, US
Ben C. Askew - Newbury Park CA, US
Kaustav Biswas - Calabasas CA, US
Jennifer N. Chau - Santa Ana CA, US
Derin C. D'Amico - Newbury Park CA, US
Scott Harried - Woodland Hills CA, US
Thomas Nguyen - Thousand Oaks CA, US
Wenyuan Qian - Camarillo CA, US
Jiawang Zhu - Simi Valley CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Qingyian Liu - Camarillo CA, US
Nobuku Nishimura - West Hills CA, US
Tanya Peterkin - Woodland Hills CA, US
Babak Riahi - Woodland Hills CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Nianhe Han - Thousand Oaks CA, US
Rana Nomak - Westlake Village CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/54
A61K 31/4965
C07D 241/04
C07D 265/30
C07D 279/12
US Classification:
51425501, 5142275, 5142375, 544 59, 544158, 544384
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Compounds And Methods Of Use

US Patent:
7425631, Sep 16, 2008
Filed:
Apr 12, 2004
Appl. No.:
10/823377
Inventors:
Robert D. Groneberg - Boulder CO, US
Derin C. D'Amico - Newbury Park CA, US
James Zhan - Shanghai, CN
Andras Toro - Toronto, CA
Youngboo Kim - Osaka, JP
David A. Mareska - Longmont CO, US
Nianhe Han - Thousands Oaks CA, US
Christopher H. Fotsch - Thousands Oaks CA, US
Qingyian Liu - Camarillo CA, US
Babak Riahi - Woodland Hills CA, US
Kevin Yang - San Gabriel CA, US
Aiwen Li - Westlake Village CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Kaustav Biswas - Calabasas CA, US
Scott Harried - Woodland Hills CA, US
Thomas Nguyen - Thousand Oaks CA, US
Wenyuan Qian - Camarillo CA, US
Jian Jeffrey Chen - Newbury Park CA, US
Rana Nomak - Westlake Village CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
Array BioPharma Inc. - Boulder CO
International Classification:
C07D 215/04
US Classification:
546192, 548530, 548557, 549 51, 549 58, 549 59
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Glycine Transporter-1 Inhibitors

US Patent:
7538114, May 26, 2009
Filed:
Jun 26, 2007
Appl. No.:
11/823027
Inventors:
Stephen Hitchcock - Westlake Village CA, US
Albert Amegadzie - Moorpark CA, US
Wenyuan Qian - Camarillo CA, US
Xiaoyang Xia - Thousand Oaks CA, US
Scott S. Harried - Woodland Hills CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4965
A01N 43/62
A61K 31/55
A01N 43/00
A61K 31/33
C07D 243/08
C07D 245/00
C07D 241/04
C07D 295/00
US Classification:
51425504, 514183, 514218, 540575, 540470, 544396, 544384
Abstract:
The present invention provides compounds that are glycine transporter 1 (hereinafter referred to as GlyT-1) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of GlyT1 such as cognitive disorders associated with Schizophrenia, ADHD (attention deficit hyperactivity disorder), MCI (mild cognitive impairment), and the like. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

Beta-Secretase Modulators And Methods Of Use

US Patent:
7745484, Jun 29, 2010
Filed:
Nov 10, 2006
Appl. No.:
11/595187
Inventors:
Wenge Zhong - Thousand Oaks CA, US
Stephen Hitchcock - Westlake Village CA, US
Brian K. Albrecht - Cambridge MA, US
Michael D. Bartberger - Sherman Oaks CA, US
James Brown - Moorpark CA, US
Ryan Brown - Watertown MA, US
Stuart C. Chaffee - Philadelphia PA, US
Yuan Cheng - Newbury Park CA, US
Michael Croghan - Thousand Oaks CA, US
Russell Graceffa - Hampton NH, US
Scott Harried - Woodland Hills CA, US
Dean Hickman - Moorpark CA, US
Dan Horne - Thousand Oaks CA, US
Randall Hungate - San Francisco CA, US
Ted Judd - Simi Valley CA, US
Matthew Kaller - Ventura CA, US
Charles Kreiman - Watertown MA, US
Daniel La - Brookline MA, US
Patricia Lopez - West Hills CA, US
Craig Masse - Cambridge MA, US
Holger Monenschein - Camarillo CA, US
Thomas Nguyen - Thousand Oaks CA, US
Thomas Nixey - Newbury Park CA, US
Vinod F. Patel - Acton MA, US
Lewis Pennington - Ventura CA, US
Matthew Weiss - Boston MA, US
Qiufen Xue - Newbury Park CA, US
Bryant Yang - Simi Valley CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/352
C07D 311/96
US Classification:
514454, 549331
Abstract:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I.

Beta-Secretase Modulators And Methods Of Use

US Patent:
7838676, Nov 23, 2010
Filed:
Nov 14, 2006
Appl. No.:
11/599901
Inventors:
Qiufen Xue - Newbury Park CA, US
Brian K. Albrecht - Cambridge MA, US
Denise Lyn Andersen - Simi Valley CA, US
Michael Bartberger - Sherman Oaks CA, US
James Brown - Moorpark CA, US
Ryan Brown - Belmont MA, US
Stuart C. Chaffee - Philadelphia PA, US
Yuan Cheng - Newbury Park CA, US
Michael Croghan - Thousand Oaks CA, US
Russell Graceffa - Hampton NH, US
Scott Harried - Woodland Hills CA, US
Stephen Hitchcock - Westlake Village CA, US
Randall Hungate - Camarillo CA, US
Ted Judd - Simi Valley CA, US
Matthew Kaller - Ventura CA, US
Charles Kreiman - Watertown MA, US
Daniel La - Brookline MA, US
Patricia Lopez - West Hills CA, US
Craig Masse - Cambridge MA, US
Holger Monenschein - Camarillo CA, US
Thomas Nguyen - Thousand Oaks CA, US
Thomas Nixey - Newbury Park CA, US
Vinod F. Patel - Acton MA, US
Lewis Pennington - Camarillo CA, US
Matthew Weiss - Boston MA, US
Bryant Yang - Simi Valley CA, US
Wenge Zhong - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 498/02
C07D 401/00
US Classification:
546 18, 546115
Abstract:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I.

Beta-Secretase Modulators And Methods Of Use

US Patent:
7872009, Jan 18, 2011
Filed:
Nov 14, 2006
Appl. No.:
11/600264
Inventors:
Brian K. Albrecht - Cambridge MA, US
Denise Lyn Andersen - Simi Valley CA, US
Michael Bartberger - Sherman Oaks CA, US
James Brown - Moorpark CA, US
Ryan Brown - Belmont MA, US
Stuart C. Chaffee - Philadelphia PA, US
Yuan Cheng - Newbury Park CA, US
Michael Croghan - Thousand Oaks CA, US
Russell Graceffa - Hampton NH, US
Scott Harried - Woodland Hills CA, US
Stephen Hitchcock - Westlake Village CA, US
Randall Hungate - Camarillo CA, US
Ted Judd - Simi Valley CA, US
Matthew Kaller - Ventura CA, US
Charles Kreiman - Watertown MA, US
Daniel La - Brookline MA, US
Patricia Lopez - West Hills CA, US
Craig Masse - Cambridge MA, US
Holger Monenschein - Camarillo CA, US
Thomas Nguyen - Thousand Oaks CA, US
Thomas Nixey - Newbury Park CA, US
Vinod F. Patel - Acton MA, US
Lewis Pennington - Camarillo CA, US
Matthew Weiss - Boston MA, US
Qiufen Xue - Newbury Park CA, US
Bryant Yang - Simi Valley CA, US
Wenge Zhong - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/50
US Classification:
51425201, 544238, 544298, 544408, 546242, 549398
Abstract:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I.

Beta-Secretase Modulators And Methods Of Use

US Patent:
7973047, Jul 5, 2011
Filed:
May 13, 2010
Appl. No.:
12/779858
Inventors:
Wenge Zhong - Thousand Oaks CA, US
Stephen Hitchcock - Westlake Village CA, US
Brian K. Albrecht - Cambridge MA, US
Michael D. Bartberger - Sherman Oaks CA, US
James Brown - Moorpark CA, US
Ryan Brown - Belmont MA, US
Stuart C. Chaffee - Philadelphia PA, US
Yuan Cheng - Newbury Park CA, US
Michael Croghan - Thousand Oaks CA, US
Russell Graceffa - Hampton NH, US
Scott Harried - Woodland Hills CA, US
Dean Hickman - Moorpark CA, US
Daniel Horne - Thousand Oaks CA, US
Randall Hungate - San Francisco CA, US
Ted Judd - Simi Valley CA, US
Matthew Kaller - Ventura CA, US
Charles Kreiman - Watertown MA, US
Daniel La - Brookline MA, US
Patricia Lopez - West Hills CA, US
Craig E. Masse - Cambridge MA, US
Thomas Nixey - Newbury Park CA, US
Vinod F. Patel - Acton MA, US
Lewis Pennington - Ventura CA, US
Matthew Weiss - Boston MA, US
Qiufen Xue - Newbury Park CA, US
Bryant Yang - Simi Valley CA, US
Holger Monenschein - Camarillo CA, US
Thomas Nguyen - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/438
C07D 471/00
US Classification:
514278, 546 18
Abstract:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I.

Beta-Secretase Modulators And Methods Of Use

US Patent:
8163766, Apr 24, 2012
Filed:
Oct 21, 2010
Appl. No.:
12/909566
Inventors:
Wenge Zhong - Thousand Oaks CA, US
Stephen A. Hitchcock - Jupiter FL, US
Vinod F. Patel - Acton MA, US
Yuan Cheng - Newbury Park CA, US
Michael Croghan - Thousand Oaks CA, US
Randall W. Hungate - Camarillo CA, US
Daniel La - Brookline MA, US
Patricia Lopez - West Hills CA, US
Matthew K. Kaller - Ventura CA, US
Holger Monenschein - Camarillo CA, US
Thomas Nguyen - Newbury Park CA, US
Thomas Nixey - Newbury Park CA, US
Lewis Pennington - Ventura CA, US
Matthew Weiss - Boston MA, US
Ted Judd - Simi Valley CA, US
Russell Graceffa - Hampton NH, US
Qiufen Xue - Newbury Park CA, US
Charles Kreiman - Watertown MA, US
Brian K. Albrecht - Cambridge MA, US
Denise Lyn Andersen - Simi Valley CA, US
Michael Bartberger - Sherman Oaks CA, US
James Brown - Moorpark CA, US
Ryan Brown - Watertown MA, US
Stuart C. Chaffee - Philadelphia PA, US
Scott Harried - Woodland Hills CA, US
Craig Masse - Cambridge MA, US
Bryant Yang - Simi Valley CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/436
US Classification:
514278, 546 15, 549330
Abstract:
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I.

Possible Relatives

Ross Harried  Scott S Stanard  Scott A Standefer  Scott C Johnston  Scott S Stanfield  Scott S Stanford  Scott M Jolly  Scott W Stanger  Scott A Stangle  Scott L Stanifer 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.